deliverables

How inputs, assumptions, runs, and reports connect across the pipeline. The jumping-off point to everything else.

Where the demand envelope comes from and how it’s bounded.

Intervention onset timing: assumptions, evidence, downstream effect.

Interactive drill-down into remaining coverage headroom.

Gene-drive dynamics from first principles, for a mixed technical/policy audience.

What ships next in the scenario-report and version-bridge workstreams, the six decisions needed from the PST owner, and the effort behind each — staged for post-leave kickoff.

Why one childhood-EPI ceiling shouldn’t bound adult and endectocide products — and a menu of per-channel envelopes keyed to real coverage proxies.

Where each resistance series stands after the ACT switch to the OJ Watson study — source, method, and what to trust, product by product.

From a country-level urban guess to admin-level GHS-SMOD cities ∪ observed stephensi detections — the mismatch we found, the union rule, and what the data can’t yet tell us.

The implemented SoC cost update — Global Fund 2026 reference prices mix-weighted by real purchase volumes, delivery built from freight tables, SMC campaign budgets, and the ITN costing literature. Before/after comparison with decomposition graphics: commodities down, microscopy honestly up, SMC unchanged in total but rebuilt underneath.

The manual-acquisition list for the 2026 cost refresh — registration-gated, browser-only, PDF-locked and Internet-Archive-only sources, payoff-ranked, with the extraction traps that silently produce wrong numbers.

The manual-extraction list — registration-gated, browser-only, and PDF sources (IHME LBD, JRF, ESPEN, DHS) that take each prevention workstream from national to full subnational scope, payoff-ranked.

Does correcting the Stage-3 admin-population defect reconcile the model-vs-reference burden gap? It closes about half the deaths shortfall, widens the incidence gap, and leaves the CFR mismatch — a metric-definition difference.